Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Parichart Junpaparp, MD

LICENSE # 0101266136
 
Issue Date: 1/9/2019
Expiration Date: 2/28/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 2/10/2019
None Reported
Academic Appointments - Non-US
Last Updated 2/10/2019
None Reported
Publications
(up to ten in the last five years)
Last Updated 2/10/2019
Is Non-Ischemic Cardiomyopathy (NICM) Associated With Better Prognosis Than Ischemic Cardiomyopathy (ICM) In Heart Failure Patients?
Is Non-Ischemic Cardiomyopathy (NICM) Associated With Better Prognosis Than Ischemic Cardiomyopathy (ICM) In Heart Failure Patients?
Date: 01 2014

Prognostic value of prolonged QTc interval in patients with acute pulmonary embolism
Acta Cardiol. 2014 Oct;69(5):550-5.
Date: 01 2014

The Magnitude of Cardiovascular Change in Cirrhotic Cardiomyopathy in Predicting of Hepatorenal Syndrome
The Magnitude of Cardiovascular Change in Cirrhotic Cardiomyopathy in Predicting of Hepatorenal Syndrome
Date: 03 2014

Spontaneous coronary artery dissection following a preeclampsia pregnancy
Date: 03 2014

Tumor-like pyogenic liver abscess caused by Klebsiella pneumoniae in diabetes
Date: 03 2014

A Rare Complication of a Common Stress Test
Journal of Cardiology Cases
Date: 04 2014

Sigmoid Volvulus: Is It Related to Marfan Syndrome?
Sigmoid Volvulus: Is It Related to Marfan Syndrome?
Date: 04 2014

Coronary-Cameral Fistula and Coronary Ectasia as a Prelude to Ischemia in the Absence of Obstructive Disease
J Cardiovasc Dis Diagn 2015, 3:6
Date: 01 2015

Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) can risk stratify patients in Transcatheter Aortic-Valve Replacement (TAVR)
Int J Cardiol.
Date: 08 2016